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Abstract— Melanoma is known as the most serious type of 
skin cancer and the risk of melanoma seems to be around people 
under 40, especially women. Warning signs of skin cancer can 
help ensure that cancerous changes are discovered and cured 
before cancer has spread. Melanoma can be cured successfully 
if it is detected early. In this review, we discussed the causes, risk 
factors and prevention methods of melanoma skin cancer, which 
may lead to early detection of melanoma among people. In 
addition, this review also shows the stages of melanoma and how 
to treat melanoma skin cancer. We also highlighted the new 
suggested skin cancer treatment using cold atmospheric plasma.  
 
Index Terms— Melanoma Skin Cancer;  New Melanoma 
Treatment; Possible Side Effects Melanoma Treatment; Stages 
Of Melanoma. 
 
I. INTRODUCTION 
 
Skin cancer is the most widely recognized cancer type. 
According to Malaysia's Third National Cancer Registry 
(2003-2005) which reveals that skin cancer is the most 
common cancer growth in Malaysia, representing 2.6% of all 
cases [1]. Unlike various types of cancer, skin cancer is not 
widely considered in Malaysia, and there is little awareness 
among the general population. The World Health 
Organization (WHO) reports that the occurrence of skin 
melanoma cancer has evolved over the last decade [1]. The 
case of melanoma infection will increase 132,000 cases a 
year.  
 
A. . Overview of Melanoma Skin Cancer 
Melanoma is a type of skin cancer that usually starts in a 
certain type of skin cell. It is a disease in which cancer cells 
form in melanocytes. Melanocytes are cells that make 
melanin and it’s found in the lower part of the epidermis. 
Melanin is a pigment that gives the skin a natural color. When 
the skin is exposed to sunlight or any artificial light, 
melanocytes make more pigment and cause the skin to 
become dark. 
Melanoma skin cancer can grow anyplace on the skin, 
however they may start in storage space (middle and back) in 
men and women’s legs. Neck and face are another normal 
places that melanoma can grow. 
Melanoma skin cancer will grow deeper into human skin. 
This causes melanoma has several stages from the epidermis 
to the dermis of human skin. The treatment of melanoma is in 
accordance with its respective stages. 
Melanoma skin cancer occurs more frequently in people 
with fair skin. For people without a history of skin cancer in 
their families, no studies have been done to test the 
helpfulness of routine screening for melanoma. 
Dermatologists do not recommend skin cancer examinations, 
but because melanoma is a serious, sometimes deadly 
disease, early detection and treatment is very important. The 
dermatologist can perform a test called 3-D photography to 
screen the entire body[2]. Everyone has the risk of melanoma, 
but the increased risk relies upon a few factors which are sun 
exposure, number of moles on the skin, type of skin and 
family history (genetics).  
Being exposed to the sun is dangerous to the skin, and can 
promote skin cancer, including melanoma[2]. The best way 
to avoid melanoma is to decrease the duration that we are 
exposed to the sun. There are two categories of moles which 
are normal moles and atypical moles [2]. Atypical moles can 
be a sign of melanoma, and situates us at increased risk of 
melanoma. 
As with all skin cancers, people with more fairer skin are at 
high risk. Genetics plays a major role in melanoma skin 
cancer. Approximately one in every 10 patients detected has 
family members with a history of melanoma skin cancer. If 
our parents, siblings or children have melanoma, we are in a 
family that is easy to have melanoma skin cancer [2]. If 
melanoma skin cancer are present in our family, we can 
protect ourselves and our children with great caution to 
discover early warning signs and find cancer when it is easiest  
to treat. 
 
B. Stages of Melanoma Skin Cancer 
 
Figure 1: Stages of melanoma skin cancer. Adapted with permission from  
National Cancer Institute by Terese Winslow. Copyright (2009) 
 
Classifications for melanoma skin cancer are called stages 
as shown in Figure 1. Stage referring to the thickness of 
melanoma skin cancer has spread. Staging is used to 
determine the treatment. Early melanoma skin cancer, stage I 
cancer means the melanoma cancer cells are not penetrating 
under the skin surface. The melanoma skin cancer cells are 
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only in the surface of the skin, while stage II means there is 
melanoma skin cancer cells are in the layer under the 
epidermis  [3]. Stage III means the melanoma skin cancer 
cells are throughout the dermis and touching on the next layer 
down (the reticular dermis) [3]. More advanced melanoma 
skin cancer (Stages IV and V) has extended into the deep 
dermis and has grown into the layer of fat under the skin 
respectively.  
 
II. TREATING MELANOMA SKIN CANCER 
  
The treatments recommended by dermatologist depends on 
the stages of melanoma skin cancer. This section discusses 
the treatments that will be considered for each stage of 
melanoma. Usually, stage I and II are treated by the surgery. 
It will remove cancer as well as a part of normal skin around 
it [3]. For some patients with stage II and their lymph nodes 
containing cancer, they may be advised to use an adjuvant 
therapy after surgery [3]. Other drugs or vaccines are also 
recommended to support the treatments for stage II.  
Stage III patients require the removal of primary cancer 
along with the lymph nodes [3]. Adjuvant therapy can also 
help maintain some cancer from coming back. Another option 
is to provide radiation therapy to areas where the lymph nodes 
are removed, especially if many areas contain cancer[3]. 
Stage IV and V melanoma skin cancer are often difficult to 
treat because it already spread to the lymph nodes or another 
part of the body[3]. It often is treated by surgery or radiation 
therapy.  
Immunotherapy can also help patients with stage IV and V 
live longer. High doses seem to be effective but it also has 
worse side effects [3]. In addition, chemotherapy can also 
help but other treatments are usually tried first. Although 
chemotherapy shrinks cancer, it usually begins to grow again 
in a few months [3]. Although an advanced stage of 
melanoma skin cancer is hard to treat, people or cancer 
patients respond well to the treatment and survive for years 
after diagnosis. 
III. POSSIBLE SIDE EFFECTS FROM SUGGESTED MELANOMA 
SKIN CANCER TREATMENT 
  
For melanoma skin cancers treatment, there are a few 
suggested treatment such as surgery, immunotherapy, 
targeted therapy, chemotherapy and radiation therapy[22]. 
Each of the treatment will be used according to suitable stages 
of melanoma skin cancer. If not suitable, there will be a 
possible side effect faced by the patients.  
 
A. Surgery 
Surgery is the primary treatment option for most melanoma 
skin cancer that usually treats the initial stage of melanoma. 
Many patients are not interested in this choice as it may leave 
scarring  even though it helps ensure that cancer has been 
removed or not left the cancerous cells behind. In some cases, 
this is painful especially for wide excision. However, some 
doctors feel it can prolong the life of the patient and at least 
avoid the pain that may be due to increased cancer. 
 
B. Immunotherapy 
Stimulating your own immune system to recognize and 
destroy cancer cells more effectively and also known as 
immunotherapy is one of the choices of melanoma 
treatment[22]. This option uses several types of drugs and 
keeps the cancer cells from attacking normal cells in the body. 
The most common side effects of this drug include fatigue, 
diarrhea, skin rash and itching[22]. For patients, especially 
women may be required to undergo this choice as it may 
damage their skin and this is the reason why patients do not 
want to undergo surgery. 
 
C. Targeted Therapy 
Targeted therapy used the drug to target melanoma cells 
which makes it different from normal cells[22]. This option 
works differently from the chemotherapy process and also 
has less severe side effects such as fatigue and hair loss[22]. 
Although it provides some common side effects but can 
sometimes have serious effects including heart rhythm 
problems, severe liver problems and allergic reactions[22]. 
Targeted therapies are the least preferred method of treating 
melanoma as a result of potentially serious side effects. 
 
D. Chemotherapy 
Chemotherapy is a common option for treating cancer 
including skin cancer[3,22]. It uses a drug that kills cancer 
cells. Drugs are injected into the veins or taken by the mouth 
as a pill. They move through the blood flow to all parts of the 
body and attack cancer cells that have spread out of the skin. 
It does not work but it can relieve symptoms or extend life to 
some patients. Similar to immunotherapy and targeted 
therapy, chemotherapy also provides some side effects such 
as hair loss, diarrhea and fatigue[3,22]. This seems to give a 
second even for patients to choose this treatment. 
  
E. Radiation Therapy 
Radiation therapy uses high-energy radiation such as x-rays 
or particles to kill cancer cells[22]. Radiation therapy is not 
often used to treat melanoma on the skin, although it is 
sometimes used if surgery is not an option for some reasons 
especially diabetes mellitus patients. Side effects of radiation 
are usually restricted to areas with radiation. Common side 
effects may include skin color changes, hair loss, nausea and 
fatigue[22]. 
The suggested melanoma treatment showed several 
advantages and disadvantages toward patients. Then, all 
melanomas patients need to do the screening process and 
getting advice or motivation from any dermatological 
doctors. This can prevent from having any possible side 
effects from the treatment. However, treatment of melanomas 
gets more improvement and this can be a solution to prevent 
any side effect and make melanomas’ patients better. 
Nowadays, many treatments showed its capability to treat 
melanoma and it also been proving in the clinical trials. One 
of the advancing melanomas treatment is based on the 
atmospheric pressure plasma.  
IV. NEW TREATMENT FOR MELANOMA SKIN CANCER 
  
Nowadays, there are several alternatives treatment for 
melanoma skin cancer. In addition, this kind of treatments has 
their side effects toward patients. In order to avoid the 
possible side effects, we have another option or alternative 
that known as cold atmospheric plasma treatment. Cold 
atmospheric plasma has shown capability in treating cancer 
cells (lung cancer, bladder cancer tumors (ScaBER) and 
breast cancer). We suggest treating melanoma using cold 
atmospheric plasma (CAP) due to the potential application in 
melanoma treatment. it is also based on the experimental 
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result that shows the effect of the CAP on various cancer cells 
that can support the skin cancer treatment[4-30]  
Recently, CAP's effects act as a helpful method for anti-
cancer treatment including for melanoma skin cancer. Many 
researchers have studied on the application of the CAP on 
melanoma skin cancer cells[ 4-30].  
In melanoma skin cancer treatments, Arndt et al. mentioned 
that cold atmospheric plasma (CAP) could induce the 
apoptosis of melanoma skin cancer cells. It is because after 
two minutes of CAP treatment approximately 30% apoptotic 
cells was achieved[4]. Interestingly, CAP shows  high 
efficacy in promoting apoptosis in melanoma skin cancer 
cells, compared to anti-tumor agents such as disulfiram, 
indirubin derivative and isoflavone genistein[4].  
Brooks et al. showed that CAP could treat melanoma skin 
cancer cells through necrosis at higher doses which is 15 s of 
treatment time. CAP treatment starts the behavior of 
apoptosis in the cells not through the growth media poisoning 
in which cells exist but through direct contact with the cell 
[5].  
In addition, Mimbrera et al. also observed that CAP 
composed of chemically active species that can be cytotoxic 
or cause cell death[6]. This active species can cause changes 
in cellular morphology and cell mobility. When CAP applied 
on cancer cells, apoptosis was induced due to the active 
species.  
Intracellular reactive oxygen species (ROS) also one of the 
active species that were induced from the CAP treatment. 
Sensenig et al. reported that CAP treatment might provide a 
method to treat melanoma skin cancer by induction of 
apoptosis[7]. Induction of apoptosis by CAP treatment occurs 
through the establishment of intracellular ROS. Production of 
ROS also induced the DNA damage and caused the cell death.  
Then,  Iseki et al. also investigated that most of the cells 
become smaller after plasma treatment and these changes are 
characteristic of apoptotic cells[8]. Cells experienced 
apoptosis but not necrosis. Most of the cells in the treated 
region detach from the dish when treated more than 180 s, 
while the cell in the untreated region remained adherent[8]. 
Cells around treated region remained attached to the dish. The 
proliferation rate of the cells also reduced after plasma 
treatment[8].  
Kim et al. detected that cancer cells begin to remove from 
the surface after plasma treatment[9]. Morphological changes 
in treated cells may indicate further involvement in cellular 
metabolic processes with great damage, since cell detachment 
from ECM can promote apoptosis [9]. Cellular damage is 
observed depending on plasma doses. Plasma with a low 
applied voltage causes the cells to burst, cell resistance and 
apoptosis, while the plasma with the higher voltage leads to 
the necrosis of cellular characteristics. Cytotoxicity has 
increased dramatically with increased voltage used, which 
shows the destruction of membrane cells by plasma [10-13]. 
Based on the reviews, this demonstrates the ability of cold 
atmospheric plasma treatment on skin cancer treatment. 
 
A. Effects and Mechanisms of Action of Cold 
Atmospheric Plasma on Cancer Cells 
CAP is a gas composed of multiple chemically active 
species such as reactive oxygen and nitrogen[14,15]. It 
induces either physical or chemical changes on cell surfaces 
upon application. Different studies presented various aspects 
of CAP application in skin cancer treatment such as the role 
of reactive species that effect on the oxidative stress and cause 
cell apoptosis in skin cancer depends on the CAP doses [20, 
24, 25, 25, 27]. Oxidative stress may play different roles in 
the melanoma skin cancer treatments. Melanoma skin cancer 
cells exhibit oxidative stress which could damage 
surrounding tissue.  
The reactive species also was the key mechanism of plasma 
effects on the cell that lead to induction of the apoptosis of 
cancer cells. Apoptosis is a type of programmed cell death, 
and mitochondria act as the major regulator of apoptosis. 
Induction of apoptosis is an important issue in cancer 
treatment. CAP has been studied by the researcher as a 
possible therapy for induction of apoptosis especially in 
melanoma skin cancer treatment [16-18].  
Cancer cells show a weak antioxidant mechanism compared 
to normal cells. This property can attack selective cancer cells 
by CAP which is delivered by reactive oxygen species and 
reactive nitrogen species, resulting in severe oxidative stress 
and cell death [16]. Schmidt et al. observed that redox 
changes due to the CAP's treatment result in changes in cell 
morphology. Changes in cell morphology can also cause cell 
apoptosis [10]. 
When applied directly or indirectly to cancer cells, CAP has 
been shown to give the effects on oxidative stress and induce 
cell apoptosis via multiple pathways including reactive 
oxygen and nitrogen species[16-19]. Therefore, we suggested 
further investigation of CAP, including the chemical reaction 
and also the safety of CAP as a therapy for melanoma skin 
cancer. 
V. CONCLUSION 
   
This review provides a better understanding of melanoma 
skin cancer and its treatment. Additionally, it provides an idea 
to investigate new melanoma treatments for early detection 
and avoid the worst cases. Finally, these findings will play a 
role to improve the treatment of skin melanoma skin using a 
new and advanced atmospheric plasma device that can be 
used as a clinical tool to diagnose early melanoma skin 
cancer. 
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